International Stem Cell Corp (ISCO)
0.065
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
International Stem Cell Profit Margin (Quarterly): -24.25% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.25% |
| September 30, 2023 | -6.64% |
| June 30, 2023 | 26.72% |
| March 31, 2023 | -1.63% |
| December 31, 2022 | 0.95% |
| September 30, 2022 | -20.14% |
| June 30, 2022 | -0.10% |
| March 31, 2022 | -0.45% |
| December 31, 2021 | -19.04% |
| September 30, 2021 | -8.96% |
| June 30, 2021 | 11.78% |
| March 31, 2021 | -36.13% |
| December 31, 2020 | -48.85% |
| September 30, 2020 | -36.73% |
| June 30, 2020 | -59.93% |
| March 31, 2020 | -15.81% |
| December 31, 2019 | -95.63% |
| September 30, 2019 | 0.14% |
| June 30, 2019 | -27.92% |
| March 31, 2019 | -40.85% |
| December 31, 2018 | -46.24% |
| September 30, 2018 | 3.79% |
| June 30, 2018 | -12.97% |
| March 31, 2018 | -31.52% |
| December 31, 2017 | -75.41% |
| Date | Value |
|---|---|
| September 30, 2017 | -117.2% |
| June 30, 2017 | 32.24% |
| March 31, 2017 | -153.8% |
| December 31, 2016 | |
| September 30, 2016 | 21.31% |
| June 30, 2016 | |
| March 31, 2016 | -901.8% |
| December 31, 2015 | -77.45% |
| September 30, 2015 | -25.23% |
| June 30, 2015 | 39.83% |
| March 31, 2015 | -79.35% |
| December 31, 2014 | -253.1% |
| September 30, 2014 | -103.6% |
| June 30, 2014 | -277.7% |
| March 31, 2014 | -87.02% |
| December 31, 2013 | -159.5% |
| September 30, 2013 | -227.5% |
| June 30, 2013 | -151.0% |
| March 31, 2013 | -133.2% |
| December 31, 2012 | -208.4% |
| September 30, 2012 | -175.3% |
| June 30, 2012 | -234.6% |
| March 31, 2012 | -248.6% |
| December 31, 2011 | -247.1% |
| September 30, 2011 | -304.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-95.63%
Minimum
Dec 2019
26.72%
Maximum
Jun 2023
-19.08%
Average
-15.81%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 12.23% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -2.40% |
| Gross Profit Margin (Quarterly) | 54.31% |
| Operating Margin (Quarterly) | -22.45% |
| Return on Net Operating Assets | -2.58% |